Correction to: Neuropsychopharmacology advance online publication, 30 January 2013; doi: https://doi.org/10.1038/npp.2012.246
In this article, there are errors in page 2, right column, fifth and sixth lines in the ‘Drugs’ section: the sentence should read ‘Scrambled GLYX-13 (proline-threonine-proline-threonine-NH2) was purchased from Bachem (USA).’ Also in figure 1 legend, the second line should read ‘scrambled GLYX-13 (PTPT-NH2; 3 mg/kg, IV)’.
Rights and permissions
About this article
Cite this article
Burgdorf, J., Zhang, Xl., Nicholson, K. et al. Correction: GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without ketamine-like Side Effects. Neuropsychopharmacol 38, 1374 (2013). https://doi.org/10.1038/npp.2013.42
Published:
Issue Date:
DOI: https://doi.org/10.1038/npp.2013.42